Fredrik Dahl
Förmögenhet: 444 692 $ per 2026-05-31
Förmögenhet: 444 692 $ per 2026-05-31
Fredrik Dahl is the founder of Colibri Ventures AB,Pixelgen Technologies AB. Currently, Dr. Dahl is Chairman at Faboss Invest AB, Director at Devyser Diagnostics AB starting 2025, Director at Nucleus Capital AB, and Director at Llya Pharma AB. Formerly, Dr. Dahl was Director at Moligo Technologies AB, Chief Technology Officer at Halo Genomics AB, and Chief Technology Officer at Vanadis Diagnostics AB. Education includes undergraduate and doctorate degrees from the University of Uppsala.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
DEVYSER DIAGNOSTICS AB 0,27 % | 2025-05-07 | 44 150 ( 0,27 % ) | 444 692 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| DEVYSER DIAGNOSTICS AB | Direktör/Styrelseledamot | 2021-01-01 |
Colibri Ventures AB | Grundare | - |
Faboss Invest AB | Ordförande | - |
Nucleus Capital AB | Direktör/Styrelseledamot | - |
Pixelgen Technologies AB
Pixelgen Technologies AB Packaged SoftwareTechnology Services Develops bio-analytical tools for immune cell surface protein | Grundare | - |
Llya Pharma AB | Direktör/Styrelseledamot | - |
| Företag | Position | Slut |
|---|---|---|
Vanadis Diagnostics AB
Vanadis Diagnostics AB Miscellaneous Commercial ServicesCommercial Services Develops novel solution for non-invasive prenatal testing | Teknisk/Vetenskaplig/F&U Direktör | - |
Halo Genomics AB
Halo Genomics AB Medical/Nursing ServicesHealth Services Develops products for preparation of DNA for the next generation sequencing platforms | Teknisk/Vetenskaplig/F&U Direktör | - |
Moligo Technologies AB
Moligo Technologies AB BiotechnologyHealth Technology Engages in producing ultrapure DNA | Direktör/Styrelseledamot | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 10 |
|---|---|
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Halo Genomics AB
Halo Genomics AB Medical/Nursing ServicesHealth Services Develops products for preparation of DNA for the next generation sequencing platforms | Health Services |
Devyser Diagnostics AB
Devyser Diagnostics AB Medical SpecialtiesHealth Technology Manufactures and sells diagnostic kits | Health Technology |
Vanadis Diagnostics AB
Vanadis Diagnostics AB Miscellaneous Commercial ServicesCommercial Services Develops novel solution for non-invasive prenatal testing | Commercial Services |
Colibri Ventures AB | |
Faboss Invest AB | |
Moligo Technologies AB
Moligo Technologies AB BiotechnologyHealth Technology Engages in producing ultrapure DNA | Health Technology |
Pixelgen Technologies AB
Pixelgen Technologies AB Packaged SoftwareTechnology Services Develops bio-analytical tools for immune cell surface protein | Technology Services |
Nucleus Capital AB | |
Llya Pharma AB |
Välj din utgåva
All finansiell information anpassad till den nationella nivån